Biotechnology News and Research

RSS

Nordion presents TheraSphere Phase II trial results against liver metastases at SIR meeting

Nordion Inc., a leading provider of products and services to the global health science market, today shared results from the first multi-site, Phase II clinical trial to evaluate TheraSphere® for treatment of metastatic liver cancer.

29 Mar 2011

USPTO issues Notice of Allowance to Modular's green surfactant patent application

Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.

29 Mar 2011

ADDF awards Yuma $249,810 grant for Alzheimer's research

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $249,810 to Yuma Therapeutics Corporation to develop small molecules to treat Alzheimer's disease.

28 Mar 2011

CRANE ChemPharma to launch Saunders PV Life Science Diaphragm and S360 Actuator at INTERPHEX 2011

CRANE ChemPharma Flow Solutions is pleased to introduce two new products from its Saunders brand during INTERPHEX 2011.

28 Mar 2011

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.

28 Mar 2011

FDA approves ipilimumab for metastatic melanoma treatment

The U.S. Food and Drug Administration announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer.

28 Mar 2011

Genentech's Lucentis Phase III trials in DME meets primary endpoints

Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.

28 Mar 2011

XTL announces MinoGuard acquisition

XTL announced on March 24, 2011, it entered into a term sheet to acquire the activity of MinoGuard Ltd. by obtaining an exclusive license to use MinoGuard's entire technology in return for royalties on sales and milestone payments throughout the clinical development process.

25 Mar 2011

Isotechnika fourth quarter consolidated net loss increases to $2.42 million

Isotechnika Pharma Inc. has released its financial results for the fourth quarter and year ended December 31, 2010 and provided a review of the Company's operational and financial progress for 2010 and to the current date.

25 Mar 2011

Tengion 2010 adjusted net loss decreases to $25.8 million

Tengion, Inc. today provided a business update and reported its financial results for the year ended December 31, 2010.

25 Mar 2011

Covaris launches Bench-top SF220 Formulation Processing System

Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.

25 Mar 2011

P&G, Teva sign partnership agreement for consumer health care

The Procter & Gamble Company and Teva Pharmaceutical Industries Ltd. today announced the signing of a master agreement to create a partnership in consumer health care by bringing together both companies' existing over-the-counter medicines and complementary capabilities to accelerate growth.

25 Mar 2011

Althea extends labeling, packaging of biological product services through Sherpa

Althea Technologies, Inc. announced today that it has extended its service offering to include labeling, packaging, storage and distribution of drug and biological products through its co-marketing partner, Sherpa Clinical Packaging.

25 Mar 2011

Wolters Kluwer Health offers free online resources to Japan for earthquake relief

In support of disaster relief efforts in Japan following the recent earthquake and tsunami, Ovid and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, are providing free online access to emergency, disaster, trauma, and radiation contamination resources to Japanese hospitals and healthcare institutions affected by the disasters via the Wolters Kluwer Health Emergency Resources Portal.

25 Mar 2011

BrainStorm provides review of recent accomplishments for shareholders, investors

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, today provided a review of recent accomplishments for shareholders and investors.

25 Mar 2011

VisualSonics introduces Vevo LAZR system to advance cancer research

VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., today announced the launch of the Vevo LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.

25 Mar 2011

Agilent opens new lab facility in Bangalore, India

Agilent Technologies Inc. has expanded its Life Sciences and Chemical Analysis Center of Excellence in Bangalore.

25 Mar 2011

Molecular Devices signs distribution agreement with ChanTest

Molecular Devices, Inc. and ChanTest Corporation, leading providers of ion channel and GPCR drug discovery tools and solutions, have signed an agreement for Molecular Devices to distribute ChanTest's extensive portfolio of ion channel and GPCR cell lines on a non-exclusive basis.

25 Mar 2011

Oncolytics completes patient enrollment in REOLYSIN Phase 2 trial against head, neck cancers

Oncolytics Biotech Inc. today announced that it has completed patient enrollment in its U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers.

25 Mar 2011

Boehringer Ingelheim formally acquires Amgen's Fremont manufacturing site

Today Boehringer Ingelheim formally acquired Amgen's biopharmaceutical development and manufacturing facility in Fremont, California. This acquisition involves leasing buildings, acquiring physical equipment and assuming manufacturing processes done at the Fremont site.

25 Mar 2011

Biotechnology News and Research

Nordion presents TheraSphere Phase II trial results against liver metastases at SIR meeting

USPTO issues Notice of Allowance to Modular's green surfactant patent application

ADDF awards Yuma $249,810 grant for Alzheimer's research

CRANE ChemPharma to launch Saunders PV Life Science Diaphragm and S360 Actuator at INTERPHEX 2011

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

FDA approves ipilimumab for metastatic melanoma treatment

Genentech's Lucentis Phase III trials in DME meets primary endpoints

XTL announces MinoGuard acquisition

Isotechnika fourth quarter consolidated net loss increases to $2.42 million

Tengion 2010 adjusted net loss decreases to $25.8 million

Covaris launches Bench-top SF220 Formulation Processing System

P&G, Teva sign partnership agreement for consumer health care

Althea extends labeling, packaging of biological product services through Sherpa

Wolters Kluwer Health offers free online resources to Japan for earthquake relief

BrainStorm provides review of recent accomplishments for shareholders, investors

VisualSonics introduces Vevo LAZR system to advance cancer research

Agilent opens new lab facility in Bangalore, India

Molecular Devices signs distribution agreement with ChanTest

Oncolytics completes patient enrollment in REOLYSIN Phase 2 trial against head, neck cancers

Boehringer Ingelheim formally acquires Amgen's Fremont manufacturing site

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News